Enzymatica AB (OSTO:ENZY) Long-Term Capital Lease Obligation : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Enzymatica AB Long-Term Capital Lease Obligation?

Enzymatica AB's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Enzymatica AB's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr2.01 Mil) but then declined from Dec. 2023 (kr2.01 Mil) to Mar. 2024 (kr0.00 Mil).

Enzymatica AB's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (kr1.12 Mil) to Dec. 2022 (kr0.25 Mil) but then increased from Dec. 2022 (kr0.25 Mil) to Dec. 2023 (kr2.01 Mil).

Enzymatica AB Long-Term Capital Lease Obligation Historical Data

The historical data trend for Enzymatica AB's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Long-Term Capital Lease Obligation Chart

Enzymatica AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.77

1.82

1.12

0.25

2.01

Enzymatica AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	2.01	-

Enzymatica AB (OSTO:ENZY) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Enzymatica AB Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymatica AB (OSTO:ENZY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (OSTO:ENZY) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

EN9:Germany

Address

Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70

Website

http://www.enzymatica.se

Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (OSTO:ENZY) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016